Calprotectin in Chronic Prosthetic Joint Infection

NCT05060952 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-09-29

No results posted yet for this study

Summary

A bacterial infection of an artificial joint is a serious complication that often requires additional surgery to exchange the arthroplasty. It is also difficult to recognize an infected joint, as the symptoms caused by the infection are very similar to those of other problems with arthroplasties, such as loosening of the implant. To improve the ability to diagnose prosthetic joint infections, this study compares the levels of calprotectin, a specific inflammatory protein, in the joint fluid of infected joints and joints with other complications. The underlying hypothesis is that the level of calprotectin in infected joints is significantly higher, thus facilitating the diagnosis of prosthetic joint infection.

Conditions

  • Prosthetic Joint Infection
  • Prosthetic Infection
  • Arthroplasty Complications

Interventions

DIAGNOSTIC_TEST

Calprotectin Lateral Flow Test

Semiquantitative point of care photometric assay for the calprotectin level in joint fluid aspirate

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2023-12-31
Completion
2025-12-31
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05060952 on ClinicalTrials.gov